| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/STROKEAHA.108.520668 |
| P698 | PubMed publication ID | 18703803 |
| P50 | author | Lauren Sansing | Q89437873 |
| Brett L Cucchiara | Q101573211 | ||
| P2093 | author name string | Scott Kasner | |
| Patrick Lyden | |||
| Steven Messe | |||
| CHANT Investigators | |||
| P433 | issue | 11 | |
| P304 | page(s) | 2993-2996 | |
| P577 | publication date | 2008-08-14 | |
| P1433 | published in | Stroke Journal | Q7624282 |
| P1476 | title | Hematoma growth in oral anticoagulant related intracerebral hemorrhage | |
| P478 | volume | 39 |
| Q83291458 | Anti-adrenergic medications and edema development after intracerebral hemorrhage |
| Q35992110 | Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage |
| Q34447650 | Association Factors for CT Angiography Spot Sign and Hematoma Growth in Korean Patients with Acute Spontaneous Intracerebral Hemorrhage : A Single-Center Cohort Study |
| Q47838584 | Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality |
| Q47185519 | Before-After Study of an Electronic Order Set for Reversal of Vitamin K Antagonist-Associated Intracerebral Hemorrhage. |
| Q37978627 | Challenges and controversies in the medical management of primary and antithrombotic-related intracerebral hemorrhage |
| Q98194136 | Clinical Impact of Hematoma Expansion in Left Ventricular Assist Device Patients |
| Q52599660 | Clinical and Radiographic Predictors of Intracerebral Hemorrhage Outcome. |
| Q91368428 | Combining Investigation of Imaging Markers (Island Sign and Blend Sign) and Clinical Factors in Predicting Hematoma Expansion of Intracerebral Hemorrhage in the Basal Ganglia |
| Q37968783 | Complications of intracerebral haemorrhage |
| Q88302794 | Early Outcome after Intracranial Hemorrhage Related to Non-Vitamin K Oral Anticoagulants |
| Q37865085 | Emergency reversal of antiplatelet agents in patients presenting with an intracranial hemorrhage: a clinical review |
| Q46827302 | Emergency reversal of clopidogrel in the setting of spontaneous intracerebral hemorrhage |
| Q38007885 | Etiologies of intracerebral hematomas |
| Q38682353 | Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine. |
| Q35711431 | Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association |
| Q38734794 | Hematoma Expansion following Intracerebral Hemorrhage: Mechanisms Targeting the Coagulation Cascade and Platelet Activation. |
| Q88084069 | Hematoma Heterogeneity on Noncontrast Computed Tomography Predicts Intracerebral Hematoma Expansion: A Meta-Analysis |
| Q37095550 | Hematoma expansion following acute intracerebral hemorrhage |
| Q90082820 | Hemicraniectomy for Supratentorial Primary Intracerebral Hemorrhage: A Retrospective, Propensity Score Matched Study |
| Q39209982 | Hemostasis in Intracranial Hemorrhage |
| Q38075630 | Individual characteristics and management decisions affect outcome of anticoagulated patients with intracranial hemorrhage |
| Q50798013 | Intracerebral haemorrhage in a population-based stroke registry (LuSSt): incidence, aetiology, functional outcome and mortality. |
| Q57482499 | Intracerebral haemorrhage: current approaches to acute management |
| Q84483212 | Is platelet activity important in acute intracerebral hemorrhage? |
| Q34381680 | Location and characteristics of warfarin associated intracranial hemorrhage. |
| Q48626887 | Low-dose Prothrombin Complex Concentrate for Warfarin-Associated Intracranial Hemorrhage with INR Less Than 2.0. |
| Q41531083 | Management of Spontaneous Intracerebral Hemorrhage |
| Q33750215 | Management of anticoagulant-related intracranial hemorrhage: an evidence-based review. |
| Q56381361 | Management of major bleeding and outcomes in patients treated with direct oral anticoagulants: results from the START-Event registry |
| Q90198322 | Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use |
| Q27342135 | Modeling intracerebral hemorrhage growth and response to anticoagulation |
| Q37598901 | New avenues for treatment of intracranial hemorrhage |
| Q37802983 | Nontraumatic Intracranial Hemorrhage |
| Q47839864 | Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts. |
| Q37900185 | Oral anticoagulant-associated intracerebral hemorrhage |
| Q52655249 | Predicting Prognosis of Intracerebral Hemorrhage (ICH): Performance of ICH Score Is Not Improved by Adding Oral Anticoagulant Use. |
| Q46191310 | Predictors of hematoma expansion predictors after intracerebral hemorrhage |
| Q50020974 | Prior antiplatelet therapy is not associated with larger hematoma volume or hematoma growth in intracerebral hemorrhage. |
| Q57808968 | Prothrombin complex concentrate versus placebo, no intervention, or other interventions in critically bleeding patients associated with oral anticoagulant administration: a protocol for a systematic review of randomised clinical trials with meta-anal |
| Q37306733 | Real world usage of PCC to "rapidly" correct warfarin induced coagulopathy |
| Q86071253 | Restarting oral anticoagulants after intracerebral hemorrhage: cons |
| Q92384616 | Reversal of warfarin anticoagulation in geriatric traumatic brain injury due to ground-level falls |
| Q37618616 | Role of antiplatelet agents in hematoma expansion during the acute period of intracerebral hemorrhage |
| Q39852573 | Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage. |
| Q99616760 | Sensitivity and specificity of blood-fluid levels for oral anticoagulant-associated intracerebral haemorrhage |
| Q34354859 | Severe non-traumatic bleeding events detected by computed tomography: do anticoagulants and antiplatelet agents have a role? |
| Q36933765 | Should anticoagulation be resumed after intracerebral hemorrhage? |
| Q34654443 | Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document". |
| Q40950987 | The HEP Score: A Nomogram-Derived Hematoma Expansion Prediction Scale |
| Q37172710 | The challenge of designing a treatment trial for warfarin-associated intracerebral hemorrhage |
| Q33728274 | The persisting burden of intracerebral haemorrhage: can effective treatments be found? |
| Q35729599 | Therapeutic strategies in acute intracerebral hemorrhage |
| Q40475411 | Timing of INR reversal using fresh-frozen plasma in warfarin-associated intracerebral hemorrhage. |
| Q35993214 | Translating basic science research to clinical application: models and strategies for intracerebral hemorrhage. |
| Q58565194 | Treatment of apixaban- and rivaroxaban-associated major bleeding using 4-factor prothrombin complex concentrate |
| Q37788997 | Treatment of coagulopathy in intracranial hemorrhage |
Search more.